Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples

Gynecologic Oncology

Volumn 93, Issue 1, 2004, Pages 54-58

  Ohashi, Yoko ^a   Kaneko, Saori J ^b   Cupples, Tommy E ^c   Young, S Robert ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c Palmetto Richland Memorial Hospital   (United States)

Author keywords

Amplification; Breast cancer; FISH; UQCRFS1

Indexed keywords

UBIQUINOL CYTOCHROME C REDUCTASE;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; ONCOGENE; PRIORITY JOURNAL; UBIQUINOL CYTOCHROME C REDUCTASE GENE;

ADULT; AGED; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL; ELECTRON TRANSPORT COMPLEX III; FEMALE; GENE AMPLIFICATION; HUMANS; MIDDLE AGED;

EID: 1842477931     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.01.019     Document Type: Article

References (31)

1. Rieske J.S. Composition, structure, and function of complex III of the respiratory chain. Biochim. Biophys. Acta. 456:1976;195-247.
2. Trumpower B.L., Edwards C.A. Purification of a reconstitutively active iron-sulfur protein (oxidation factor) from succinate cytochrome c reductase complex of bovine heart mitochondria. J. Biol. Chem. 254:1979;8697-8706.
3. Pennacchio L.A., Bergmann A., Fukushima A., Okubo K., Salemi A., Lennon G.G. Structure, sequence and location of the UQCRFS1 gene for the human Rieske Fe-S protein. Gene. 155:1995;207-211.
4. Sait S.N., Qadir M.U., Conroy J.M., Matsui S., Nowak N.J., Baer M.R. Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer. 34:2002;42-47.
5. Kaneko J.S., Gerasimova T., Smith S.T., Lloyd K.O., Suzumori K., Young S.R. CA125 and UQCRFS1 FISH studies of ovarian carcinoma. Gynecol. Oncol. 90:2003;29-36.
6. James L.A., Mitchell E.L., Menasce L., Varley J.M. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma. Oncogene. 14:1997;1059-1065.
7. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O.P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer. 21:1998;177-184.
8. Bürki N.G., Caduff R., Walt H., Moll C., Pejovic T., Haller U.et al. Comparative genomic hybridization of fine needle aspirates from breast carcinomas. Int. J. Cancer. 88:2000;607-613.
9. Tuquet C., Dupont J., Mesneau A., Roussaux J. Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria. Cell Biol. Toxicol. 16:2000;207-219.
10. Goormaghtigh E., Huart P., Brasseur R., Ruysschaert J.M. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives. Biochim. Biophys. Acta. 861:1986;83-94.
11. Nicolay K., de Kruijff B. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Biochim. Biophys. Acta. 892:1987;320-330.
12. Yin B.W.T., Lloyd K.O. Molecular cloning of the CA125 ovarian cancer antigen. J. Biol. Chem. 276:2001;27371-27375.
13. Morrison L.E., Legator M. Multicolor fluorescence in situ hybridization techniques. Andreeff D., Pinkel D. Introduction to fluorescence in situ hybridization: principles and clinical applications. 1999;3-12 Wiley-Liss, Inc. New York.
14. Young S.R., Liu W.H., Brock J., Smith S.T. ERBB2 and chromosome 17 centromere studies of ovarian cancer by fluorescence in situ hybridization. Genes Chromosomes Cancer. 16:1996;130-137.
15. Glick B.S., Beasley E.M., Schatz G. Protein sorting in mitochondria. Trends Biochem. Sci. 17:1992;453-459.
16. Hartl F.U., Neupert W. Protein sorting to mitochondria: evolutionary conservations of folding and assembly. Science. 247:1990;930-938.
17. Sarto C., Marocchi A., Sanchez J.C., Giannone D., Frutiger S., Golaz O. et al. Renal cell carcinoma and normal kidney protein expression. Electrophoresis. 18:1997;599-604.
18. Schapira A.H., Cooper J.M., Morgan-Hughes J.A., Landon D.N., Clark J.B. Mitochondrial myopathy with a defect of mitochondrial-protein transport. N. Engl. J. Med. 323:1990;37-42.
19. Slipetz D.M., Aprille J.R., Goodyer P.R., Rozen R. Deficiency of complex III of the mitochondrial respiratory chain in a patient with facioscapulohumeral disease. Am. J. Hum. Genet. 48:1991;502-510.
20. Fiskum G., Starkov A., Polster B.M., Chinopoulos C. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann. N.Y. Acad. Sci. 991:2003;111-119.
21. Varbiro G., Veres B., Gallyas F. Jr., Sumegi B. Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic. Biol. Med. 31:2001;548-558.
22. Zhou Y., Hileman E.O., Plunkett W., Keating M.J., Huang P. Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood. 101:2003;4098-4104.
23. Gille L., Nohl H. The ubiquinol/bc1 redox couple regulates mitochondrial oxygen radical formation. Arch. Biochem. Biophys. 388:2001;34-38.
24. Hileman E.O., Liu J., Albitar M., Keating M.J., Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol. 53:2004;209-219.
25. Thompson F.H., Nelson M.A., Trent J.M., Guan X.Y., Liu Y., Yang J.M.et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies. Cancer Genet. Cytogenet. 87:1996;55-62.
26. Cheng J.Q., Ruggeri B., Klein W.M., Sonoda G., Altomare D.A., Watson D.K.et al. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Natl. Acad. Sci. U.S.A. 93:1996;3636-3641.
27. Höglund M., Gorunova L., Andren-Sandberg A., Dawiskiba S., Mitelman F., Johansson B. Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: frequent loss of 19p13.3 and gain of 19q13.1-13.2. Genes Chromosomes Cancer. 21:1998;8-16.
28. Schleger C., Arens N., Zentgraf H., Bleyl U., Verbeke C. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J. Pathol. 191:2000;27-32.
29. Lin L., Prescott M.S., Zhu Z., Singh P., Chun S.Y., Kuick R.D.et al. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res. 60:2000;7021-7027.
30. Bellacosa A., de Feo D., Godwin A.K., Bell D.W., Cheng J.Q., Altomare D.A.et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas. Int. J. Cancer. 64:1995;280-285.
31. Courjal F., Louason G., Speiser P., Katsaros D., Zeillinger R., Theillet C. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer. 69:1996;247-253.